Development & Manufacturing

Development & Manufacturing


Peptide

Offering cutting-edge, comprehensive peptide solutions

Apextide is focused on providing cutting-edge, comprehensive peptide solutions to biopharmaceutical companies and research institutions worldwide. Our industry-leading technology platform provides our customers with full cycle peptide services from early stage development to commercial production.


With more than 20 years of experience in peptide development and production, the company's scientific team is able to support a wide range of projects from early discovery to commercial production, with service scales ranging from mg to ton. Our peptide service platform has superior synthesis capabilities to support a wide variety of peptide types, including linear, cyclic, stapled and highly modified peptides, to meet the customized needs of different customers.


Through an innovative solid-liquid phase combination method, Apextide can mass-produce high-purity, side-chain modified long chains and complex peptides, and has extensive practical experience in the field of complex peptide projects. In addition to core technical services, we also provide value-added services such as API analysis and CMC submission writing to fully help customers accelerate the market process of peptide drugs.


Apextide is committed to helping biopharmaceutical companies accelerate the development and commercialization of peptide drugs through innovative technologies and professional services.

Peptide

advantage

That's why you chose us

Team advantage

More than 70% of the R&D team members have master's or doctoral degrees, and the core team members have accumulated more than 20 years of research and development experience in the field of peptides.

Technical strength

Rich practical experience in solving difficult sequences.

Professional team

The company has a professional business and technical team, can quickly respond to customer needs, and communicate with customers efficiently.

Industry cooperation

We have established cooperative relations with a number of internationally renowned pharmaceutical companies and research institutions, and successfully undertaken a number of drug development projects.

Customized service

To provide customers with flexible customized projects, to be able to quickly deliver high-quality products.

Critical equipment

Critical equipment for making drugs

Laboratory scale equipment

SyroI parallel peptide synthesizer

Automatic purifier

Bottle freeze-drying machine

YMC (LAB100, FC500)

Freeze-drying machine (0.2㎡)

DAC system (DAC100)

 

 

Polit scale equipment

Semi-automatic peptide synthesizer (5L, 10L, 20L, 50L)

Semi-automatic peptide lysator 20L

Lysation-precipitation peptide reactor 100L

Film evaporation instrument

YMC (FC1500, K-PrepEX06KG-HPW)

DAC system (DAC150, DAC300, DAC450)

200mm spring column

Freeze-drying machine (0.5㎡, 1㎡, 5㎡)

Capabilities

Capabilities

Our R&D capabilities at all stages of production

01

Laboratory scale

10 R&D lines;
Batch: 0.1-200 mmol (100 g per batch);
Annual output: 5-10 kg/ year

02

Pilot scale

3 production lines;
Batch: 200-1,500 mmol (2,000g per batch);
Annual output: 20-50 kg/year

03

Commercial scale

Annual production capability: >1 ton

Capabilities